Skip to main content
. 2022 Sep 16;12:953790. doi: 10.3389/fonc.2022.953790

Figure 2.

Figure 2

Oncologic outcomes of pNCT group and TNT group (A) Overall survival (B) Disease-free survival; (C) Cumulative incidence of locoregional recurrence; (D) Cumulative incidence of distant metastases. pNCT prolonged neoadjuvant chemotherapy; TNT total neoadjuvant therapy.